In this video, Motley Fool health-care analyst David Williamson talks about some of the biggest investing stories in the health-care space today. He tells us about Pfizer (NYSE: PFE) and Bristol-Myers Squibb's (NYSE: BMY) latest European victory, a major insurance win for obesity-drug maker VIVUS (NASDAQ:VVUS), a huge vote of share-price confidence for Sarepta (NASDAQ: SRPT) and its drug for Duchenne muscular dystrophy, and a big tumble for St. Jude Medical (NYSE: STJ) after another problem with one of its products.
Motley Fool analyst David Williamson takes us through some major health-care jumps and tumbles.
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Follow @motleydavid
